Depression and coronary heart disease.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3514821)

Published in ISRN Cardiol on November 22, 2012

Authors

Karina W Davidson1

Author Affiliations

1: Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University, New York, NY 10032, USA.

Articles cited by this

(truncated to the top 100)

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry (1981) 18.92

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04

Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (2007) 15.96

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA (2003) 10.59

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet (1998) 9.29

A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24

Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36

Going from evidence to recommendations. BMJ (2008) 7.30

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA (2007) 7.11

Patient adherence and medical treatment outcomes: a meta-analysis. Med Care (2002) 7.10

Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01

Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care (2004) 6.09

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med (2004) 6.00

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J (2007) 5.92

Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA (2000) 5.91

Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med (1993) 5.85

The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33

Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA (2000) 5.31

Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J (2006) 5.19

Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation (2008) 5.15

Cost of lost productive work time among US workers with depression. JAMA (2003) 5.13

Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09

Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA (1990) 4.70

The neurobiology of stress: from serendipity to clinical relevance. Brain Res (2000) 4.51

Circadian variation and triggers of onset of acute cardiovascular disease. Circulation (1989) 4.48

Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry (2007) 4.44

Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44

Screening and case-finding instruments for depression: a meta-analysis. CMAJ (2008) 4.23

Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry (2001) 4.18

Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med (2002) 4.10

Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry (1998) 3.83

Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation (1992) 3.78

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation (2003) 3.75

Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry (1992) 3.71

Depression, heart rate variability, and acute myocardial infarction. Circulation (2001) 3.57

Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55

The cost-utility of screening for depression in primary care. Ann Intern Med (2001) 3.38

Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27

Developing clinically valid practice guidelines. J Eval Clin Pract (1995) 3.26

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry (2002) 3.18

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol (2001) 3.16

Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med (2003) 3.16

Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry (2007) 2.96

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91

Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87

Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2004) 2.84

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord (1998) 2.75

Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73

Screening and case finding instruments for depression. Cochrane Database Syst Rev (2005) 2.67

Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation (1998) 2.64

The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry (2004) 2.62

Disability and depression among high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry (1992) 2.56

Measuring outcomes in patients with depression or anxiety: an essential part of clinical practice. Med J Aust (2002) 2.55

Socioeconomic status, race, and diurnal cortisol decline in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom Med (2006) 2.52

Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50

Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44

'Subthreshold' mental disorders. A review and synthesis of studies on minor depression and other 'brand names'. Br J Psychiatry (1999) 2.36

Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med (2005) 2.36

Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology (2000) 2.36

Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34

Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw Expansion. J Am Coll Cardiol (2004) 2.32

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28

Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol (2006) 2.23

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J (2006) 2.22

The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19

Depression and 1-year prognosis in unstable angina. Arch Intern Med (2000) 2.13

Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med (2010) 2.12

Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med (2001) 2.09

Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med (2005) 2.08

Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychol Med (2003) 2.07

Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology (2001) 2.06

Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981-2004. Acta Psychiatr Scand (2007) 2.02

Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics (2004) 1.98

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96

Relationships among infant sleep patterns, maternal fatigue, and development of depressive symptomatology. Birth (2005) 1.93

Heart rate variability during specific sleep stages. A comparison of healthy subjects with patients after myocardial infarction. Circulation (1995) 1.89

Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol (1995) 1.73

Depression in patients with coronary heart disease. Am J Med (2008) 1.73

Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord (1995) 1.65

Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol (1997) 1.61

Recent evidence linking coronary heart disease and depression. Can J Psychiatry (2006) 1.60

Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev (2007) 1.59

Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med (2006) 1.57

Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J (1999) 1.57

Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res (2000) 1.57

Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol (2002) 1.55

What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. Ann Intern Med (2012) 1.54

Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry (2003) 1.53

Depression and cardiovascular disease: a call for recognition. Circulation (2005) 1.53